Insider Transactions in Q1 2024 at Integra Lifesciences Holdings Corp (IART)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2024
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,024
-1.52%
|
$70,840
$35.88 P/Share
|
|
Mar 12
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-0.64%
|
$12,145
$35.88 P/Share
|
|
Mar 12
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,438
-1.11%
|
$50,330
$35.88 P/Share
|
|
Mar 12
2024
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,012
-1.69%
|
$70,420
$35.88 P/Share
|
|
Mar 11
2024
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
20,283
+13.94%
|
-
|
|
Mar 11
2024
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,410
-2.46%
|
$86,760
$36.22 P/Share
|
|
Mar 11
2024
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-1.1%
|
$7,380
$36.22 P/Share
|
|
Mar 11
2024
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
205
+1.09%
|
-
|
|
Mar 11
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,410
+11.11%
|
-
|
|
Mar 11
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.54%
|
$4,680
$36.22 P/Share
|
|
Mar 11
2024
|
Lea Daniels Knight EVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,105
+20.15%
|
-
|
|
Mar 11
2024
|
Chantal Veillon Berteloot EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
11,758
+20.43%
|
-
|
|
Mar 11
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
16,028
+11.66%
|
-
|
|
Mar 11
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-2.72%
|
$49,356
$36.22 P/Share
|
|
Mar 11
2024
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
20,503
+15.65%
|
-
|
|
Mar 11
2024
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
3,922
-4.57%
|
$141,192
$36.22 P/Share
|
|
Mar 10
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
799
-1.56%
|
$28,764
$36.73 P/Share
|
|
Mar 10
2024
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,655
-2.93%
|
$95,580
$36.73 P/Share
|
|
Mar 10
2024
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
635
-1.27%
|
$22,860
$36.73 P/Share
|
|
Mar 10
2024
|
Harvinder Singh EVP & PRESIDENT, INTERNATIONAL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,179
+50.0%
|
-
|
|
Mar 10
2024
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.85%
|
$12,456
$36.73 P/Share
|
|
Mar 10
2024
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
346
+1.82%
|
-
|
|
Mar 10
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-0.57%
|
$9,936
$36.73 P/Share
|
|
Mar 06
2024
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Open market or private sale
|
Direct |
8,348
-14.33%
|
$300,528
$36.59 P/Share
|
|
Mar 06
2024
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Exercise of conversion of derivative security
|
Direct |
8,736
+13.04%
|
$279,552
$32.59 P/Share
|
|
Feb 20
2024
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
3,516
+7.11%
|
-
|
|
Feb 20
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
2,564
+4.77%
|
-
|
|
Feb 20
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
808
+3.22%
|
-
|
|
Feb 20
2024
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
3,721
+6.99%
|
-
|
|
Jan 18
2024
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-3.15%
|
$25,074
$42.39 P/Share
|
|
Jan 18
2024
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
597
+3.05%
|
-
|